Day One Biopharma Expands to ADCs with $55M Drug Acquisition
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
- Latest
- Trending
"Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
"Digits boosts its financial tools with Basis Finance acquisition, enhancing FP&A capabilities amid a challenging financial landscape for startups."
Explore why electric vehicles like Tesla, GM, and Albemarle are poised to bring investors from rags to riches amid evolving ...
"Heroes of Mavia integrates MAVIA token on iOS & Android, ushering in Phase 2 with new features, boosting its sustainable ...
"Blade & Sorcery Version 1.0 Review: A captivating VR experience with dynamic combat and expansive Sandbox Mode, now enhanced with ...
"Cryptocurrency analysis flags caution with bearish RSI divergences, declining active addresses, and critical IOMAP insights by analyst Jake."
Understanding long-term perspective, resilience, and key investing principles is crucial for market success, as indicated by a steady RSI above ...
Shiba Shootout leads the meme ecosystem with a strong utility focus and clear roadmap. Engage with the team on Telegram ...
Polygon NFTs surge with Moon Girl; BlockDAG presale hits $50.4M; Sheldon The Sniper and Bluntz bullish on BNB. Join BlockDAG ...
Invest in the BlockDAG presale now at blockdag.network. Join their Telegram for updates. Note: Always conduct your own research before ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.